Cite
HARVARD Citation
Kirouac, D. et al. (n.d.). Clinical responses to ERK inhibitor (GDC-0994) treatment combinations predicted using a Quantitative Systems Pharmacology model of MAPK signaling in BRAF(V600E)-mutant colorectal cancer. European journal of cancer. pp. S20-. [Online].